secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001628908-23-000014
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health Q4 revenue up 54% to $382.4M; new partnerships to add $250M+ in 2024
--------------------------------------------------------------------------------

- Q4 revenue $382.4M (+54% YoY); net loss $11.3M; Adjusted EBITDA $32.3M (8.4% margin).
- Full year 2022 revenue $1,352M (+48.9% YoY); net loss $19.2M; Adjusted EBITDA $106.3M (7.9% margin).
- Total Lives on Platform 20.6M as of Dec 31, 2022, up from 17.7M a year ago.
- New Performance Suite deal with 5th largest US health insurer for oncology in FL/AZ, expected to drive >$250M revenue in 2024.
- New risk-based agreement with large regional health plan within Evolent Care Partners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000014/0001628908-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000014/evh-20230222.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer